Antigenicity of low molecular weight surfactant species.
The authors tested the antigenicity of human lung surfactant isolated from amniotic fluid. Mice and rabbits were immunized. Rabbit polyclonal antisera to these surfactant preparations were absorbed with normal human plasma proteins. Polyclonal antisera reacted with both high molecular weight (35 kd) surfactant apoprotein and to lower molecular weight species, both 18 kd and 9 kd. Mice were used to generate monoclonal antibodies to surfactant. Enzyme-linked immunosorbant assay was used to identify five monoclonal antibodies that reacted with surfactant. By Western blot analysis, all of these recognized a low molecular weight surfactant species (9 kd) that could be either SP-B or SP-C. One reacted with a 37 kd protein in the surfactant preparation, consistent with SP-A. One monoclonal antibody also recognized a higher molecular weight species (44 kd) of unknown origin. The ability of antisera and monoclonal antibodies to inhibit the functional activity of surfactant was assayed using a pulsating bubble surfactometer. Rabbit polyclonal antisera inhibited initial surface adsorption to equilibrium surface tension and increased the minimum surface tension after 1 and 5 minutes of initiation of pulsations. This inhibitory activity of the antisera was noted in divalent F(ab')2 fragments. Monovalent F(ab) fragments and control normal rabbit sera did not inhibit surfactant function in this assay. Of the anti-surfactant monoclonal antibodies that reacted with surfactant by ELISA and Western blot, three inhibited its capacity to lower surface tension on the pulsating bubble apparatus. The other two monoclonal antibodies showed no functional inhibitory activity. It is concluded that both the 35 kd SP-A and the 9 kd proteins of human surfactant are highly immunogenic and partially crossreactive. Resulting antibodies could alter the ability of surfactant to perform its physiologic function, ie, to lower surface tension.
Strayer
D S
DS
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston 77030.
Merritt
T A
TA
Makunike
C
C
Hallman
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000941:Antigens; D001059:Apoproteins / Q000032:analysis / Q000276:immunology; D015153:Blotting, Western; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007114:Immunization; D008171:Lung Diseases / Q000276:immunology; D051379:Mice; D008970:Molecular Weight; D011233:Precipitin Tests; D011510:Proteolipids / Q000032:analysis / Q000276:immunology; D011817:Rabbits; D013501:Surface-Active Agents / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000941:Antigens; D001059:Apoproteins; D007106:Immune Sera; D011510:Proteolipids; D013501:Surface-Active Agents